Searched for
FY27 PHARMA OUTLOOK
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...- AI fear over IT overdone, but near-term pain likely to persist: Seshadri SenIndian IT services face persistent pressure due to AI disruption fears, with market expert Seshadri Sen advising tactical caution despite a...
- Nifty IT crashes 6% to 3-year low as Infosys, HCL Tech, other IT stocks crash up to 9%. Time to buy the dip?The Nifty IT index slumped over 6% to a three-year low after Accenture’s guidance cut triggered a sharp sell-off in Infosys, TCS, HCLTech a...
- TCS, Infosys, Wipro, other IT stocks crash up to 8% as Accenture lowers FY26 guidanceIndian IT stocks, including TCS and Infosys, tumbled up to 8% after Accenture lowered its annual revenue growth forecast, signaling continu...
- MTAR Technologies shares surge 5%, deliver multibagger returns of 138% in just 3 monthsMTAR Technologies shares surged to a fresh 52-week high, extending a remarkable 138% rally in three months. Strong international order wins...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- Govt targets 69% jump in FY27 rural road constructionIndia plans to construct 26,474 kilometers of rural roads this financial year. This target marks a significant 69% increase in road buildin...
- Infosys ADRs crash over 8%, Wipro falls 6% after Accenture cuts annual revenue forecastInfosys and Wipro ADRs plunged following Accenture’s reduced FY26 revenue forecast. This downgrade highlights enterprise caution regarding ...
- Buy, Sell or Hold: Goldman Sachs remains neutral on Tata Motors; Nuvama maintains buy on HULBrokerages show selective optimism amidst market jitters. Goldman Sachs backs Shyam Metalics & Energy with a 10% upside target, anticipatin...
- JLR projects revenue growth and return to profit in FY27, doubles down on USJaguar Land Rover anticipates a strong comeback in financial year 2027. The company projects a 13% revenue increase and a return to profita...
- Oil below $80 may cap fuel price hikes, boost India outlookFalling crude oil prices below $80 a barrel are set to prevent further fuel price increases. This development is boosting India's economic ...
- NBFCs and private banks better positioned than PSU banks: Aman ChowhanAman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...
- India's export outlook is challenging for FY27, but worst is over: Elara SecuritiesIndia's export outlook remains challenging in FY27 amid moderating global demand and elevated electronics imports, but the worst phase appe...
- Pakistan sees room to improve FY27 outlook after Iran war ends, says Finance Minister AurangzebPakistan's Finance Minister Muhammad Aurangzeb sees potential economic upsides for fiscal year 2027 following the end of the Iran conflict....
- Market trading guide: NDR Auto among 2 stock recommendations for TuesdayImproved investor sentiment following the interim US-Iran peace agreement has supported equities as crude fell below $85, easing inflation ...
- Quarter after quarter, year after year, India is fastest growing economy: FM SitharamanFinance Minister Nirmala Sitharaman said India remains the world's fastest-growing major economy and accused Congress leader Rahul Gandhi o...
- World Bank Raises India's FY27 Growth Forecast to 6.6%India's economic growth forecast for FY27 has been raised to 6.6 percent by the World Bank. This positive outlook is driven by reduced US t...
- India Inc remains bullish on FY27; Telecom, defence, banking seen driving growth: ReportIndian businesses are optimistic about FY27. Telecom, defence, metals, and banking are set for growth. Companies expect demand to remain st...
- Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
